Folgen
Eike Gallmeier
Eike Gallmeier
Department of Internal Medicine, Klinikum Memmingen
Bestätigte E-Mail-Adresse bei klinikum-memmingen.de
Titel
Zitiert von
Zitiert von
Jahr
Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?
M Kerschensteiner, E Gallmeier, L Behrens, VV Leal, T Misgeld, ...
The Journal of experimental medicine 189 (5), 865-870, 1999
12951999
In vivo Therapeutic Responses Contingent on Fanconi Anemia/BRCA2 Status of the Tumor
MS Van Der Heijden, JR Brody, DA Dezentje, E Gallmeier, ...
Clinical cancer research 11 (20), 7508-7515, 2005
1912005
Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer
JM Winter, AH Ting, F Vilardell, E Gallmeier, SB Baylin, RH Hruban, ...
Clinical cancer research 14 (2), 412-418, 2008
1602008
Functional defects in the fanconi anemia pathway in pancreatic cancer cells
MS Van der Heijden, JR Brody, E Gallmeier, SC Cunningham, ...
The American journal of pathology 165 (2), 651-657, 2004
1572004
Targeted Disruption of FANCC and FANCG in Human Cancer Provides a Preclinical Model for Specific Therapeutic Options
E Gallmeier, ES Calhoun, C Rago, JR Brody, SC Cunningham, T Hucl, ...
Gastroenterology 130 (7), 2145-2154, 2006
1502006
Ultra-fast high-resolution agarose electrophoresis of DNA and RNA using low-molarity conductive media
JR Brody, ES Calhoun, E Gallmeier, TD Creavalle, SE Kern
Biotechniques 37 (4), 598-602, 2004
1072004
Inhibition of ataxia telangiectasia-and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133+ …
E Gallmeier, PC Hermann, MT Mueller, JG Machado, A Ziesch, ...
Stem Cells 29 (3), 418-429, 2011
1062011
A syngeneic variance library for functional annotation of human variation: application to BRCA2
T Hucl, C Rago, E Gallmeier, JR Brody, M Gorospe, SE Kern
Cancer research 68 (13), 5023-5030, 2008
1042008
Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays
ES Calhoun, T Hucl, E Gallmeier, KM West, DE Arking, A Maitra, ...
Cancer research 66 (16), 7920-7928, 2006
1012006
Knock-in of Mutant K-ras in Nontumorigenic Human Epithelial Cells as a New Model for Studying K-ras–Mediated Transformation
H Konishi, B Karakas, AM Abukhdeir, J Lauring, JP Gustin, JP Garay, ...
Cancer research 67 (18), 8460-8467, 2007
1002007
JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand
SR Mucha, A Rizzani, AL Gerbes, P Camaj, WE Thasler, CJ Bruns, ...
Gut 58 (5), 688-698, 2009
812009
Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer
E Punkenburg, T Vogler, M Büttner, K Amann, M Waldner, R Atreya, ...
Gut 65 (7), 1139-1150, 2016
792016
High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor–dependent MCAT motif
T Hucl, JR Brody, E Gallmeier, CA Iacobuzio-Donahue, IK Farrance, ...
Cancer research 67 (19), 9055-9065, 2007
742007
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer-the NEONAX trial (AIO-PAK-0313), a prospective, randomized …
TJ Ettrich, AW Berger, L Perkhofer, S Daum, A König, A Dickhut, U Wittel, ...
BMC cancer 18, 1-10, 2018
702018
Absence of Specific Cell Killing of the BRCA2-Deficient Human Cancer Cell Line CAPAN1 by Poly (ADP-Ribose) Polymerase Inhibition
E Gallmeier, SE Kern
Cancer biology & therapy 4 (7), 703-706, 2005
702005
Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor …
SC Cunningham, E Gallmeier, T Hucl, DA Dezentje, ES Calhoun, G Falco, ...
Cancer research 66 (11), 5560-5564, 2006
622006
Expression, cellular distribution, and prognostic relevance of TRAIL receptors in hepatocellular carcinoma
L Kriegl, A Jung, J Engel, R Jackstadt, AL Gerbes, E Gallmeier, JA Reiche, ...
Clinical cancer research 16 (22), 5529-5538, 2010
572010
Overexpression of heat shock protein 27 (HSP 27) increases gemcitabine sensitivity in pancreatic cancer cells through S‐phase arrest and apoptosis
Y Guo, A Ziesch, S Hocke, E Kampmann, S Ochs, EN De Toni, B Göke, ...
Journal of cellular and molecular medicine 19 (2), 340-350, 2015
552015
A blood-based multi marker assay supports the differential diagnosis of early-stage pancreatic cancer
AW Berger, D Schwerdel, A Reinacher-Schick, W Uhl, H Algül, H Friess, ...
Theranostics 9 (5), 1280, 2019
532019
Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer–a retrospective cohort study
S Kruger, M Haas, C Burkl, P Goehring, A Kleespies, F Roeder, ...
Thrombosis Research 157, 9-15, 2017
532017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20